Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 513, Suchdauer: 1.24s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study

von Sedat Yildirim ; Ozlem Nuray Sever ; Ezgi Turkoglu ; et al.

Clinical Medicine Insights: Oncology, Vol 20 (2026)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

2
Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma

von Sila Oksuz ; Oguzcan Kinikoglu ; Ugur Ozkerim ; et al.

Journal of Cancer Research and Clinical Oncology, Vol 152, Iss 1, Pp 1-8 (2026)

Schlagworte: Gustave roussy immune score (GRIm score); Malignant melanoma; Nivolumab; Immunotherapy biomarkers; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

3
Evolving treatment strategies for HER2-altered non–small-cell lung cancer: the rise of TKIs and ADCs

von Sevinc Balli ; Tugba Basoglu ; Mustafa Ozdogan

Frontiers in Oncology, Vol 16 (2026)

Schlagworte: antibody–drug conjugate; brain metastases; HER2-mutant NSCLC; resistance mechanisms; targeted therapy; tyrosine kinase inhibitor; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

4
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

von Nargiz Majidova ; Hacı Arak ; Faruk Recep Ozalp ; et al.

Scientific Reports, Vol 15, Iss 1, Pp 1-8 (2025)

Schlagworte: Adjuvant therapy; Dabrafenib plus trametinib; Chemotherapy; Immune checkpoint inhibitors; Melanoma; Survival outcomes; Medicine; Science
- View full text via DOI
Merkliste

5
Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study

von Ugur Ozkerim ; Oguzcan Kinikoglu ; Sila Oksuz ; et al.

Medicina, Vol 62, Iss 1, p 99 (2026)

Schlagworte: HER2-positive metastatic colorectal cancer; CEA kinetics; systemic inflammatory markers; NLR; SII; first-line chemotherapy; Medicine (General); R5-920
- View full text via DOI
Merkliste

6
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy

von Sedat Yildirim ; Akif Dogan ; Goncagul Akdag ; et al.

Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

Schlagworte: Early breast cancer; Neoadjuvant chemotherapy; Laboratory index; Pathologic complete response; Medicine; Science
- View full text via DOI
Merkliste

7
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer

von Ezgi Turkoglu ; Goncagul Akdag Topal ; Sedat Yıldırım ; et al.

Medicina, Vol 61, Iss 6, p 1075 (2025)

Schlagworte: Khorana Risk Score; venous thromboembolism; overall survival; metastatic gastric cancer; Medicine (General); R5-920
- View full text via DOI
Merkliste

8
Impact of Age and Menopausal Status on T-DM1 (Ado-Trastuzumab Emtansine) Treatment Outcomes in HER2-Positive Breast Cancer

von Heves Surmeli ; Deniz Isik ; Oguzcan Kinikoglu ; et al.

Pharmaceuticals, Vol 18, Iss 6, p 931 (2025)

Schlagworte: breast cancer; menopausal status; Trastuzumab Deruxtecan (TDM-1); treatment response; side effects; metastasis; Medicine; Pharmacy and materia medica; RS1-441
- View full text via DOI
Merkliste

9
Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine

von Sila Oksuz ; Oguzcan Kinikoglu ; Ugur Ozkerim ; et al.

Medicina, Vol 61, Iss 5, p 819 (2025)

Schlagworte: HER2-positive breast cancer; trastuzumab emtansine; T-DM1; immunohistochemistry; progression-free survival; overall survival; Medicine (General); R5-920
- View full text via DOI
Merkliste

10
Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis

von Sedat Yildirim ; Ozkan Alan ; Zeynep Yuksel Yasar ; et al.

Medicina, Vol 60, Iss 8, p 1374 (2024)

Schlagworte: disease-free survival; non-small-cell lung cancer; overall survival; prognostic factor; tumor spread through air spaces; Medicine (General); R5-920
- View full text via DOI
Merkliste

11
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?

von Goncagul Akdag ; Deniz Isik ; Akif Dogan ; et al.

Medicina, Vol 60, Iss 8, p 1372 (2024)

Schlagworte: colon cancer; T4N0 stage; adjuvant treatment; Medicine (General); R5-920
- View full text via DOI
Merkliste

12
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

von Ozkan Alan ; Tugba Akin Telli ; Bilge Aktas ; et al.

World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)

Schlagworte: Breast cancer; Neoadjuvant treatment; Insulin resistance; HOMA-IR; Inflammation-based indices; Pathological complete response; Surgery; RD1-811; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

13
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis

von Yıldırım, Sedat ; Başoğlu, Tugba ; Doğan, Akif ; et al.

BMC Cancer. 25(1)
- Zum Volltext in PubMed Central
Merkliste

14
Chordoma: a case series and review of the literature

von Ozkan Alan ; Tugba Akin Telli ; Ozlem Ercelep ; et al.

Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)

Schlagworte: Advanced chordoma; Tyrosine kinases; Rare disease; Targeted therapy; Medicine
- View full text via DOI
Merkliste

15
Efficacy of Palbociclib and Ribociclib in Second-line Treatment of Metastatic Hormone Receptor-positive Breast Cancer: A Single-center Experience

von Sedat YILDIRIM ; Özlem Nuray SEVER ; Goncagül AKDAĞ TOPAL ; et al.

Journal of Oncological Sciences, Vol 11, Iss 3, Pp 224-232 (2025)

Schlagworte: cdk4/6 inhibitors; metastatic breast cancer; palbociclib; ribociclib; progression-free survival; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

16
Real-World Treatment Outcomes After Nivolumab Progression in BRAF-Negative Metastatic Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group

von Emine Bihter Eniseler ; Atike Pinar Erdogan ; Mustafa Şahbazlar ; et al.

Journal of Clinical Medicine ; Volume 15 ; Issue 13 ; Pages: 5224

Schlagworte: metastatic melanoma; nivolumab; immune checkpoint inhibitors; chemotherapy; anti-PD-1 progression
- View full text via BASE
Merkliste

17
Long-term Follow-up Results of Our Patients Diagnosed with Ductal Carcinoma In Situ: Usefulness of the Van Nuys Prognostic Index

von Özlem Nuray SEVER ; Tuğba BAŞOĞLU ; Şermin KÖKTEN ; et al.

Journal of Oncological Sciences, Vol 11, Iss 2, Pp 83-88 (2025)

Schlagworte: ductal carcinoma in situ; van nuys prognostic index; disease free survival; overall survival; radiotherapy; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

18
Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period

von İlknur Deliktaş Onur ; Oğuzcan Kınıkoğlu ; Gözde Kavgacı ; et al.

Acta Haematologica Oncologica Turcica, Vol 58, Iss 1, Pp 12-15 (2025)

Schlagworte: antibody-drug conjugates; adjuvant t-dm1; trastuzumab extensive; her2-positive breast cancer; Medicine (General); R5-920
- View full text via DOI
Merkliste

19
Impact of Metastasectomy on Survival Outcomes in Colorectal Cancer: A Single Center Retrospective Study

von Oğuzcan Kınıkoğlu ; Yunus Emre Altıntaş ; Goncagül Akdağ ; et al.

Acta Haematologica Oncologica Turcica, Vol 58, Iss 1, Pp 40-45 (2025)

Schlagworte: colorectal cancer; metastasectomy; prognosis; survival outcomes; treatment planning; Medicine (General); R5-920
- View full text via DOI
Merkliste

20
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide

von Ugur Ozkerim ; Oguzcan Kinikoglu ; Deniz Isik ; et al.

Journal of Clinical Medicine ; Volume 15 ; Issue 1 ; Pages: 386

Schlagworte: PSA kinetics; time to PSA nadir; metastatic hormone-sensitive prostate cancer; abiraterone; enzalutamide
- View full text via BASE
Merkliste

21
Efficacy of Anti-VEGF and Anti-EGFRs in Microsatellite Instable (MSI-H) Metastatic Colorectal Cancer in a Turkish Oncology Group (TOG) Cohort Study

von İlknur Deliktaş Onur ; Mutlu Doğan ; Mehmet Akif Öztürk ; et al.

Current Oncology, Vol 32, Iss 11, p 639 (2025)

Schlagworte: dMMR colorectal cancer; MSI-H colorectal cancer; anti-EGFR; anti-VEGF; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

22
Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression

von Yunus Emre Altıntaş ; Oğuzcan Kınıkoğlu ; Anıl Yıldız ; et al.

Medicina, Vol 60, Iss 12, p 2069 (2024)

Schlagworte: HER2-positive breast cancer; trastuzumab re-challenge; lapatinib capecitabine; Medicine (General); R5-920
- View full text via DOI
Merkliste

23
The Prognostic and Predictive Value of DR-70 Immunoassay, A Novel Fibrin-Associated Biomarker, in Patients with Advanced Gastrointestinal Cancers

von Tuğba AKIN TELLİ ; Nalan AKGÜL BABACAN ; Özkan ALAN ; et al.

Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 74-79 (2022)

Schlagworte: tumor markers; gastrointestinal cancers; treatment response; biomarker; prognosis; Medicine
- View full text via DOI
Merkliste

24
Prognostic Value of Tissue-Resident Memory T Cells and Tumor Microenvironmental Features in Resected Pancreatic Adenocarcinoma

von Tuğba Başoğlu ; Kadriye Ebru Akar ; Pelin Bağcı ; et al.

Balkan Medical Journal, Vol 39, Iss 1, Pp 12-20 (2022)

Schlagworte: Medicine
- View full text via DOI
Merkliste

25
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

von Oğuzcan Kınıkoğlu ; Hatice Odabas ; Yunus Emre Altıntaş ; et al.

Medicina, Vol 60, Iss 6, p 951 (2024)

Schlagworte: metastatic breast cancer; trastuzumab emtansine; endocrine therapy; pertuzumab plus trastuzumab; Medicine (General); R5-920
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag